These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10561171)

  • 1. Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients.
    Esposito M; Venturini M; Vannozzi MO; Tolino G; Lunardi G; Garrone O; Angiolini C; Viale M; Bergaglio M; Del Mastro L; Rosso R
    J Clin Oncol; 1999 Apr; 17(4):1132. PubMed ID: 10561171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of alternate sequences of epirubicin and docetaxel on the pharmacokinetic behaviour of both drugs in advanced breast cancer.
    Lunardi G; Venturini M; Vannozzi MO; Tolino G; Del ML; Bighin C; Schettini G; Esposito M
    Ann Oncol; 2002 Feb; 13(2):280-5. PubMed ID: 11886006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxoids in combination with anthracyclines and other agents: pharmacokinetic considerations.
    D'Incalci M; Schüller J; Colombo T; Zucchetti M; Riva A
    Semin Oncol; 1998 Dec; 25(6 Suppl 13):16-20. PubMed ID: 9865687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer.
    Conte PF; Baldini E; Gennari A; Michelotti A; Salvadori B; Tibaldi C; Danesi R; Innocenti F; Gentile A; Dell'Anna R; Biadi O; Mariani M; Del Tacca M
    J Clin Oncol; 1997 Jul; 15(7):2510-7. PubMed ID: 9215819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.
    Danesi R; Innocenti F; Fogli S; Gennari A; Baldini E; Di Paolo A; Salvadori B; Bocci G; Conte PF; Del Tacca M
    Br J Clin Pharmacol; 2002 May; 53(5):508-18. PubMed ID: 11994057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity.
    Venturini M; Lunardi G; Del Mastro L; Vannozzi MO; Tolino G; Numico G; Viale M; Pastrone I; Angiolini C; Bertelli G; Straneo M; Rosso R; Esposito M
    J Clin Oncol; 2000 May; 18(10):2116-25. PubMed ID: 10811677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic breast cancer with resistance to both anthracycline and docetaxel successfully treated with weekly paclitaxel.
    Ishitobi M; Shin E; Kikkawa N
    Int J Clin Oncol; 2001 Feb; 6(1):55-8. PubMed ID: 11706529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions.
    Ceruti M; Tagini V; Recalenda V; Arpicco S; Cattel L; Airoldi M; Bumma C
    Farmaco; 1999; 54(11-12):733-9. PubMed ID: 10668172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epirubicin in combination with the taxanes.
    Trudeau M; Pagani O
    Semin Oncol; 2001 Aug; 28(4 Suppl 12):41-50. PubMed ID: 11552229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancer.
    Hunz M; Jetter A; Warm M; Pantke E; Tuscher M; Hempel G; Jaehde U; Untch M; Kurbacher C; Fuhr U
    Clin Pharmacol Ther; 2007 May; 81(5):659-68. PubMed ID: 17301739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel and autonomic cardiovascular control in anthracycline treated breast cancer patients.
    Ekholm E; Rantanen V; Bergman M; Vesalainen R; Antila K; Salminen E
    Anticancer Res; 2000; 20(3B):2045-8. PubMed ID: 10928149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective taxane stimulation of epirubicinol formation in the human heart: insight into the cardiac tolerability of epirubicin-taxane chemotherapies.
    Salvatorelli E; Menna P; Gianni L; Minotti G
    J Pharmacol Exp Ther; 2007 Feb; 320(2):790-800. PubMed ID: 17135345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines.
    Budman DR; Calabro A
    Breast Cancer Res Treat; 2002 Jul; 74(1):41-6. PubMed ID: 12150451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of taxanes in the treatment of breast cancer.
    Capri G; Tarenzi E; Fulfaro F; Gianni L
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):68-75. PubMed ID: 8614849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel plus epirubicin in advanced breast cancer.
    Conte PF; Gennari A; Salvadori B; Pazzagli C; Bengala C
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):40-4. PubMed ID: 9516603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cimetidine on the pharmacokinetics of epirubicin in patients with advanced breast cancer: preliminary evidence of a potentially common drug interaction.
    Murray LS; Jodrell DI; Morrison JG; Cook A; Kerr DJ; Whiting B; Kaye SB; Cassidy J
    Clin Oncol (R Coll Radiol); 1998; 10(1):35-8. PubMed ID: 9543613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer.
    Grasselli G; Viganò L; Capri G; Locatelli A; Tarenzi E; Spreafico C; Bertuzzi A; Giani A; Materazzo C; Cresta S; Perotti A; Valagussa P; Gianni L
    J Clin Oncol; 2001 Apr; 19(8):2222-31. PubMed ID: 11304775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: a pilot study.
    Freyer G; Hennebert P; Awada A; Gil T; Kerger J; Selleslags J; Brassinne C; Piccart M; de Valeriola D
    Clin Cancer Res; 2002 Jan; 8(1):95-102. PubMed ID: 11801544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.